ADCT
Price
$2.69
Change
-$0.08 (-2.89%)
Updated
Aug 1 closing price
Capitalization
301.98M
10 days until earnings call
RGNX
Price
$8.19
Change
-$0.32 (-3.76%)
Updated
Aug 1 closing price
Capitalization
412.68M
95 days until earnings call
Interact to see
Advertisement

ADCT vs RGNX

Header iconADCT vs RGNX Comparison
Open Charts ADCT vs RGNXBanner chart's image
ADC Therapeutics SA
Price$2.69
Change-$0.08 (-2.89%)
Volume$669.03K
Capitalization301.98M
REGENXBIO
Price$8.19
Change-$0.32 (-3.76%)
Volume$539.93K
Capitalization412.68M
ADCT vs RGNX Comparison Chart in %
Loading...
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADCT vs. RGNX commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a Hold and RGNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (ADCT: $2.69 vs. RGNX: $8.51)
Brand notoriety: ADCT and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 86% vs. RGNX: 71%
Market capitalization -- ADCT: $301.98M vs. RGNX: $412.68M
ADCT [@Biotechnology] is valued at $301.98M. RGNX’s [@Biotechnology] market capitalization is $412.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • ADCT’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, ADCT is a better buy in the long-term than RGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 3 TA indicator(s) are bullish while RGNX’s TA Score has 2 bullish TA indicator(s).

  • ADCT’s TA Score: 3 bullish, 4 bearish.
  • RGNX’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ADCT is a better buy in the short-term than RGNX.

Price Growth

ADCT (@Biotechnology) experienced а -17.99% price change this week, while RGNX (@Biotechnology) price change was -6.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.14%. For the same industry, the average monthly price growth was +15.55%, and the average quarterly price growth was +36.18%.

Reported Earning Dates

ADCT is expected to report earnings on Nov 11, 2025.

RGNX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+0.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($413M) has a higher market cap than ADCT($302M). ADCT YTD gains are higher at: 35.176 vs. RGNX (5.951). ADCT has higher annual earnings (EBITDA): -95.64M vs. RGNX (-122.44M). RGNX has more cash in the bank: 268M vs. ADCT (195M). RGNX has less debt than ADCT: RGNX (79.8M) vs ADCT (123M). RGNX has higher revenues than ADCT: RGNX (157M) vs ADCT (75.8M).
ADCTRGNXADCT / RGNX
Capitalization302M413M73%
EBITDA-95.64M-122.44M78%
Gain YTD35.1765.951591%
P/E RatioN/AN/A-
Revenue75.8M157M48%
Total Cash195M268M73%
Total Debt123M79.8M154%
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
21
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADCTRGNX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 9 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LAMAX24.37N/A
N/A
Lord Abbett Dividend Growth A
GCSAX25.96N/A
N/A
Goldman Sachs Small Cap Eq Insghts A
APTTF0.07N/A
N/A
Asian Pay Television Trust
MCUJF0.94N/A
N/A
Medicure Inc.
GTDCX35.88N/A
N/A
Invesco EQV Emerging Markets All Cap C

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with DNLI. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
-3.76%
DNLI - RGNX
55%
Loosely correlated
-2.82%
ARWR - RGNX
54%
Loosely correlated
+0.82%
BEAM - RGNX
54%
Loosely correlated
-4.46%
SYRE - RGNX
53%
Loosely correlated
-4.18%
ALEC - RGNX
52%
Loosely correlated
-2.68%
More